Wall Street Experts
ver. ZuMIgo(08/25)
Medexus Pharmaceuticals Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 105
EBIT TTM (mln): 10
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
Rok finansowy |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Przychód (mln) |
0 |
0 |
3 |
4 |
3 |
5 |
8 |
25 |
52 |
80 |
77 |
108 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
20.3% |
-21.8% |
61.1% |
66.5% |
227.2% |
106.7% |
51.9% |
-3.7% |
40.9% |
Marża brutto |
0.0% |
0.0% |
100.0% |
100.0% |
65.4% |
55.2% |
50.4% |
59.1% |
56.2% |
52.7% |
49.4% |
55.5% |
EBIT (mln) |
-0 |
-0 |
-5 |
-1 |
-1 |
-1 |
-2 |
-4 |
-5 |
-1 |
-15 |
8 |
EBIT Δ r/r |
0.0% |
109873.5% |
3164.1% |
-75.2% |
-14.7% |
-42.6% |
267.7% |
101.8% |
23.2% |
-74.6% |
989.8% |
-150.8% |
EBIT (%) |
0.0% |
0.0% |
-159.1% |
-32.8% |
-35.7% |
-12.7% |
-28.1% |
-17.3% |
-10.3% |
-1.7% |
-19.6% |
7.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
3 |
6 |
10 |
12 |
14 |
EBITDA (mln) |
-0 |
-0 |
-5 |
-1 |
-3 |
-3 |
-2 |
1 |
2 |
7 |
-6 |
15 |
EBITDA(%) |
0.0% |
0.0% |
-159.1% |
-31.8% |
-113.7% |
-59.9% |
-25.6% |
5.6% |
3.3% |
8.4% |
-8.1% |
13.5% |
Podatek (mln) |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
-1 |
-3 |
-1 |
-6 |
Zysk Netto (mln) |
-0 |
-0 |
-5 |
-3 |
-2 |
-1 |
-3 |
-5 |
-4 |
-28 |
-3 |
1 |
Zysk netto Δ r/r |
0.0% |
109873.5% |
3242.3% |
-35.6% |
-45.0% |
-22.5% |
96.3% |
81.1% |
-10.0% |
542.8% |
-89.8% |
-142.4% |
Zysk netto (%) |
0.0% |
0.0% |
-162.9% |
-87.1% |
-61.3% |
-29.5% |
-34.8% |
-19.3% |
-8.4% |
-35.5% |
-3.8% |
1.1% |
EPS |
-0.0008 |
-0.27 |
-0.0694 |
-0.67 |
-0.37 |
-0.28 |
-0.47 |
-0.49 |
-0.31 |
-1.86 |
-0.15 |
0.06 |
EPS (rozwodnione) |
-0.0008 |
-0.27 |
-0.0694 |
-0.67 |
-0.37 |
-0.28 |
-0.47 |
-0.49 |
-0.31 |
-1.86 |
-0.14 |
0.06 |
Ilośc akcji (mln) |
0 |
1 |
72 |
5 |
5 |
5 |
6 |
10 |
14 |
15 |
19 |
20 |
Ważona ilośc akcji (mln) |
0 |
1 |
72 |
5 |
5 |
5 |
6 |
10 |
14 |
15 |
20 |
21 |
Waluta |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
USD |
USD |
USD |